Novel megastigmanes with lipid accumulation inhibitory and lipid metabolism-promoting activities in HepG2 cells from Sedum sarmentosum

Tetrahedron

Volumn 65, Issue 21, 2009, Pages 4142-4148

  Muraoka, Osamu ^a   Morikawa, Toshio ^a   Zhang, Yi ^b   Ninomiya, Kiyofumi ^a   Nakamura, Seikou ^b   Matsuda, Hisashi ^b   Yoshikawa, Masayuki ^a,b  

^a KINKI UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Crassulaceae; Lipid accumulation inhibitory activity; Lipid metabolism promoting activity; Megastigmane; Neosedumoside; Sedum sarmentosum

Indexed keywords

HERBACEOUS AGENT; MEGASTIGMANE; NEOSEDUMOSIDE I; NEOSEDUMOSIDE II; NEOSEDUMOSIDE III; NEOSEDUMOSIDE IV; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN HEPG2; CHEMICAL ANALYSIS; DRUG INHIBITION; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; HYDROLYSIS; LIPID METABOLISM; LIPID STORAGE; MEDICINAL PLANT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEDUM SARMENTOSUM; STEREOCHEMISTRY;

CRASSULACEAE; SEDUM SARMENTOSUM;

EID: 64649093094     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2009.03.040     Document Type: Article

References (19)

1. This paper is number 34 in the series 'Bioactive constituents from Chinese natural medicines'. The number 33:. Matsuda H., Kiyohara S., Sugimoto S., Ando S., Nakamura S., and Yoshikawa M. Biol. Pharm. Bull. 32 (2009) 147-149
2. Yoshikawa M., Morikawa T., Zhang Y., Nakamura S., Muraoka O., and Matsuda H. J. Nat. Prod. 70 (2007) 575-583
3. Morikawa T., Zhang Y., Nakamura S., Matsuda H., Muraoka O., and Yoshikawa M. Chem. Pharm. Bull. 55 (2007) 435-441
4. Ninomiya K., Morikawa T., Zhang Y., Nakamura S., Matsuda H., Muraoka O., and Yoshikawa M. Chem. Pharm. Bull. 55 (2007) 1185-1191
5. Zhang Y., Morikawa T., Nakamura S., Ninomiya K., Matsuda H., Muraoka O., and Yoshikawa M. Heterocycles 71 (2007) 1565-1576
6. 1H COSY), heteronuclear multiple-quantum coherence (HMQC), and HMBC experiments.
7. Harada N., Iwabuchi J., Yokota Y., Uda H., and Nakanishi K. J. Am. Chem. Soc. 103 (1981) 5590-5591
8. Morikawa T., Xu F., Kashima Y., Matsuda H., Ninomiya K., and Yoshikawa M. Org. Lett. 6 (2004) 869-872
9. Morikawa T., Xu F., Ninomiya K., Matsuda H., and Yoshikawa T. Chem. Pharm. Bull. 52 (2004) 494-497
10. Haines A.H., and Jenkins C.S.P. J. Chem. Soc. C (1971) 1438-1442
11. De Pascual Teresa J., Barrero A.F., San Feliciano A., Grande M., and Medarde M. Tetrahedron Lett. 43 (1978) 4141-4144
12. Kang T.H., Pae H.O., Yoo J.C., Kim N.Y., Kim Y.C., Ko G.I., and Chung H.T. J. Ethnopharmacol. 70 (2000) 177-182
13. El-Hassan A.Y., Ibrahim E.M., Al-Mulhim F.A., Nabhan A.A., and Chammas M.Y. Br. J. Radiol. 65 (1992) 774-778
14. Bellentani S., Tiribelli C., Saccoccio G., Sodde M., Fratti N., De Martin C., and Cristianini G. Hepatology 20 (1994) 1442-1449
15. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullough A.J., Forlani G., and Melchionda N. Am. J. Med. 107 (1999) 450-455
16. Marceau P., Biron S., Hould F.S., Marceau S., Simard S., Thung S.N., and Kral J.G. J. Clin. Endocrinol. Metab. 84 (1999) 1513-1517
17. Okamoto Y., Tanaka S., and Haga Y. Hepatology Res. 23 (2002) 138-144
18. Lin H.Z., Yang S.Q., Chuckaree C., Kuhajda F., Ronnet G., and Diehl A.M. Nat. Med. 6 (2000) 998-1003
19. Hawley S.A., Gadalla A.E., Olsen G.S., and Hardie D.G. Diabetes 51 (2002) 2420-2425